Profit

Near-Term Outlook Muted on Pharma Stocks: Prashasta Seth

PUBLISHED ON: October 28, 2015 | Duration: 5 min, 35 sec

  
loading..
Prashasta Seth, CEO of IIFL AMC, said pharma companies are facing pricing pressure in the US and many companies are facing regulatory issues. Until clarity emerges on these two fronts, pharma stocks may remain rangebound, he added.
ALSO WATCH
Sensex Jumps Over 250 Points To Cross 40,000 Mark

................................ Advertisement ................................

................................ Advertisement ................................